insulin icodec/semaglutide First Once-Weekly Basal Approved for Type 2 Diabetes Awiqli Once-Weekly Basal Insulin for

How much weight did people lose in the clinical trials that led to FDA approval

This is printed on the vial or the packaging

That's on the benefit side

Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns

Liu et al 59 found that compared with the insulin group, the liraglutide group could reduce serum MDA, MCP-1 and NF-B levels and increase serum SOD levels, indicating that liraglutide could reduce oxidative stress and inhibit the inflammatory response of the body

For comparison, patients on Wegovy and Ozempic both of which are injections lose about 6% of their weight in 12 weeks